Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001193125-26-269401

Options or other derivatives

  • Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Curran Daniel J. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-11 Grant or award : show line 1 in the form Stock Option (right to buy) +5,000 5,000 D
Loading xslF345X06/ownership.xml…